Related Experiment Video
Updated: Apr 18, 2026
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Mechanisms of RhoGDI2 mediated lung cancer epithelial-mesenchymal transition suppression
Huiyan Niu1, Baogang Wu, Hongfang Jiang
1Department of Geriatrics, Shengjing Hospital, China Medical University, Shenyang, China.
Background:
The aim of this study was to evaluate the function of RhoGDI2 in lung cancer epithelial-mesenchymal transition (EMT) process and to illustrate the underlying mechanisms that will lead to improvement of lung cancer treatment.
Methods:
The RhoGDI2 knock-down and overexpressing A549 cell lines were first constructed. The influence of RhoGDI2 on cytoskeleton in A549 cells was studied using two approaches: G-LISA-based Rac1 activity measurement and immunostaining-based F-actin distribution. The expression levels of key EMT genes were analyzed using real time quantitative polymerase chain reaction (RT-qPCR), western blot and immunostaining in untreated and RhoGDI2 knock-down or overexpressing A549 cells in both in vivo and in vitro experimental settings.
Results:
Our study showed that the activity of Rac1, a key gene that is crucial for the initiation and metastasis of human lung adenocarcinoma, causing the redistribution of F-actin with partial loss of cell-cell adhesions and stress fibers, was significantly suppressed by RhoGDI2. RhoGDI2 promoted the expression of EMT marker gene E-cadherin and repressed EMT promoting genes Slug, Snail, α-SMA in both A549 cells and lung and liver organs derived from the mouse models. Knocking-down RhoGDI2 induced abnormal morphology for lung organs.
Conclusion:
These findings indicate that RhoGDI2 repressed the activity of Rac1 and may be involved in the rearrangement of cytoskeleton in lung cancer cells. RhoGDI2 suppresses the metastasis of lung cancer mediated through EMT by regulating the expression of key genes such as E-cadherin, Slug, Snail and α-SMA in both in vivo and in vitro models.
Insights
Rho-GDI2 inhibits lung cancer cell metastasis by suppressing Rac1 activity and regulating epithelial-mesenchymal transition (EMT) gene expression. This finding offers potential therapeutic strategies for lung cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Lung cancer remains a leading cause of cancer-related mortality worldwide.
- Epithelial-mesenchymal transition (EMT) is a critical process in cancer metastasis.
- Understanding the molecular mechanisms regulating EMT is crucial for developing effective lung cancer therapies.
Purpose of the Study:
- To investigate the role of Rho Guanine Dissociation Inhibitor 2 (RhoGDI2) in the EMT process of lung cancer.
- To elucidate the underlying mechanisms by which RhoGDI2 influences lung cancer progression.
- To identify potential therapeutic targets for improving lung cancer treatment outcomes.
Main Methods:
- Construction of RhoGDI2 knock-down and overexpressing A549 lung cancer cell lines.
- Assessment of Rac1 activity using G-LISA and F-actin distribution via immunostaining.
- Analysis of EMT marker gene expression (E-cadherin, Slug, Snail, α-SMA) using RT-qPCR, western blot, and immunostaining in vitro and in vivo models.
Main Results:
- RhoGDI2 significantly suppressed Rac1 activity, a key mediator of lung adenocarcinoma metastasis.
- RhoGDI2 promoted E-cadherin expression while repressing Slug, Snail, and α-SMA, key EMT-promoting genes.
- RhoGDI2 knockdown led to abnormal lung organ morphology in mouse models, indicating its role in maintaining tissue structure.
Conclusions:
- RhoGDI2 plays a suppressive role in lung cancer metastasis by inhibiting Rac1 activity and modulating cytoskeleton rearrangement.
- RhoGDI2's regulation of key EMT genes (E-cadherin, Slug, Snail, α-SMA) highlights its importance in controlling cancer cell plasticity.
- These findings suggest RhoGDI2 as a potential therapeutic target for inhibiting lung cancer metastasis.
More Related Videos
Related Concept Videos
01:24Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
02:30Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:21Cell Polarization by Rho Proteins